menu
    • menu

    Company profile for CNBX Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CNBX Pharmaceuticals Inc., formerly Cannabics Pharmaceuticals Inc., is a biotechnology pharmaceutical company. The Company specializes in the discovery, development and commercialization of cannabinoid-based products and technologies for the treatment of cancer. By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future of cancer therapy. The Company’s R&D i...
    CNBX Pharmaceuticals Inc., formerly Cannabics Pharmaceuticals Inc., is a biotechnology pharmaceutical company. The Company specializes in the discovery, development and commercialization of cannabinoid-based products and technologies for the treatment of cancer. By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future of cancer therapy. The Company’s R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CNBX PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    #3 Bethesda Metro Center, Suite 700, Bethesda, MD, 20814
    Telephone
    Telephone
    (877) 424-2429
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cnbxpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CNBX to Enter the Cancer Immunotherapy Market After Acquiring TaGeza Biopharma
    CNBX to Enter the Cancer Immunotherapy Market After Acquiring TaGeza Biopharma

    08 Nov 2022

    // BIOSPACE

    https://www.biospace.com/article/releases/cnbx-to-enter-the-cancer-immunotherapy-market-after-acquiring-a-controlling-interest-in-tageza-biopharma/?s=79

    BIOSPACE
    08 Nov 2022
    Share Share
    CNBX Files PCT Patent Application For Cannabinoids Neoadjuvant Cancer Therapy
    CNBX Files PCT Patent Application For Cannabinoids Neoadjuvant Cancer Therapy

    18 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cnbx-files-new-pct-patent-application-for-cannabinoids-based-neoadjuvant-cancer-therapy-301652147.html

    PRNEWSWIRE
    18 Oct 2022
    Share Share
    CNBX Patent Application Composition for Treating Cancer
    CNBX Patent Application Composition for Treating Cancer

    13 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cnbx-patent-application-composition-and-method-for-treating-cancer-with-cannabinoids-enters-national-phase-in-us-and-israel-301648446.html

    PRNEWSWIRE
    13 Oct 2022
    Share Share
    CNBX Pharmaceuticals Announces New Patent Granted in Australia
    CNBX Pharmaceuticals Announces New Patent Granted in Australia

    28 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cnbx-pharmaceuticals-announces-new-patent-granted-in-australia-301635531.html

    PRNEWSWIRE
    28 Sep 2022
    Share Share
    CNBX Pharmaceuticals Release a New Corporate Presentation
    CNBX Pharmaceuticals Release a New Corporate Presentation

    31 May 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cnbx-pharmaceuticals-release-a-new-corporate-presentation-301557778.html

    PRNEWSWIRE
    31 May 2022
    Share Share
    CNBX Pharmaceuticals Granted Patent in Hong Kong
    CNBX Pharmaceuticals Granted Patent in Hong Kong

    05 May 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cnbx-pharmaceuticals-granted-patent-in-hong-kong-301540866.html

    PRNEWSWIRE
    05 May 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search